Lv1
40 积分 2023-11-25 加入
Revumenib: First Approval
2天前
已完结
Quizartinib for Newly Diagnosed FLT3 -ITD–Negative Acute Myeloid Leukemia: The Randomized, Double-Blind, Placebo-Controlled, Phase 2 QUIWI Study
2个月前
已完结
Diagnosis and Treatment of Polycythemia Vera
3个月前
已完结
Polycythaemia vera
3个月前
已完结
Global patterns of leukemia by subtype, age, and sex in 185 countries in 2022
3个月前
已完结
Multiple myeloma
3个月前
已完结
Cytomolecular Mechanisms of Relapse and Post‐Relapse Outcomes After Frontline FLT3 Inhibitor‐Based Therapy in FLT3‐Mutated AML
4个月前
已完结
Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3‐ITD: A multicenter phase 2 study
5个月前
已完结
Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges
6个月前
已完结
皖公网安备34019202002308
